Perrigo EBITDA 2010-2025 | PRGO

Perrigo ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Perrigo Annual EBITDA
(Millions of US $)
2024 $448
2023 $514
2022 $417
2021 $719
2020 $648
2019 $567
2018 $652
2017 $1,021
2016 $-1,567
2015 $240
2015 $931
2014 $780
2013 $839
2012 $704
2011 $593
2010 $410
2009 $321
Perrigo Quarterly EBITDA
(Millions of US $)
2025-03-31 $129
2024-12-31 $202
2024-09-30 $163
2024-06-30 $56
2024-03-31 $27
2023-12-31 $71
2023-09-30 $154
2023-06-30 $151
2023-03-31 $138
2022-12-31 $130
2022-09-30 $123
2022-06-30 $73
2022-03-31 $91
2021-12-31 $119
2021-09-30 $511
2021-06-30 $-52
2021-03-31 $141
2020-12-31 $137
2020-09-30 $175
2020-06-30 $157
2020-03-31 $179
2019-12-31 $65
2019-09-30 $156
2019-06-30 $149
2019-03-31 $197
2018-12-31 $205
2018-09-30 $-18
2018-06-30 $201
2018-03-31 $264
2017-12-31 $266
2017-09-30 $268
2017-06-30 $255
2017-03-31 $232
2016-12-31 $-366
2016-09-30 $-1,362
2016-06-30 $289
2016-03-31 $-129
2015-12-31 $-476
2015-09-30 $272
2015-06-30
2015-03-31 $247
2014-12-31 $1,199
2014-09-30 $137
2014-06-30
2014-03-31 $341
2013-12-31 $1,042
2013-09-30 $180
2013-06-30
2013-03-31 $291
2012-12-31 $920
2012-09-30 $157
2012-06-30
2012-03-31 $248
2011-12-31 $871
2011-09-30 $102
2011-06-30
2011-03-31 $199
2010-12-31 $744
2010-09-30 $112
2010-06-30
2010-03-31 $141
2009-12-31 $600
2009-09-30 $86
2009-06-30
2009-03-31 $123
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.730B $4.373B
Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.137B 27.79
Boston Scientific (BSX) United States $154.602B 38.70
Stryker (SYK) United States $145.939B 30.51
EssilorLuxottica (ESLOY) France $128.884B 0.00
Medtronic (MDT) Ireland $105.694B 14.98
Haleon (HLN) United Kingdom $51.038B 29.05
Lonza Group Ag (LZAGY) Switzerland $49.182B 0.00
ResMed (RMD) United States $35.941B 27.00
GE HealthCare Technologies (GEHC) United States $32.753B 15.55
Agilent Technologies (A) United States $32.296B 20.98
Terumo (TRUMY) Japan $27.790B 36.10
Insulet (PODD) United States $22.791B 89.46
Koninklijke Philips (PHG) Netherlands $21.581B 15.51
Zimmer Biomet Holdings (ZBH) United States $18.467B 11.86
Baxter (BAX) United States $15.754B 11.76
Smith & Nephew SNATS (SNN) United Kingdom $12.622B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.637B 0.00
Bio-Rad Laboratories (BIO) United States $6.194B 21.55
Lantheus Holdings (LNTH) United States $5.225B 13.18
Prestige Consumer Healthcare (PBH) United States $4.175B 18.65
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.309B 24.40
Haemonetics (HAE) United States $3.259B 14.85
Envista Holdings (NVST) United States $3.129B 26.00
GN Store Nord (GNNDY) Denmark $2.215B 18.35
QuidelOrtho (QDEL) United States $2.080B 14.30
LeMaitre Vascular (LMAT) United States $1.832B 40.94
AtriCure (ATRC) United States $1.687B 0.00
Neogen (NEOG) United States $1.348B 17.25
Acuren (TIC) United States $1.300B 0.00
AdaptHealth (AHCO) United States $1.212B 12.30
Kestra Medical Technologies (KMTS) United States $1.165B 0.00
Green Thumb Industries (GTBIF) United States $1.111B 25.00
BioLife Solutions (BLFS) United States $1.060B 0.00
Phibro Animal Health (PAHC) United States $1.000B 12.78
InMode (INMD) Israel $0.922B 9.29
CeriBell (CBLL) United States $0.615B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.604B 0.00
Evolus (EOLS) United States $0.602B 0.00
Curaleaf Holdings (CURLF) Canada $0.582B 0.00
Valneva SE (VALN) France $0.535B 0.00
Owens & Minor (OMI) United States $0.502B 4.17
Tilray Brands (TLRY) Canada $0.468B 0.00
Capricor Therapeutics (CAPR) United States $0.461B 0.00
Surmodics (SRDX) United States $0.422B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.366B 0.00
SNDL (SNDL) Canada $0.342B 0.00
Cresco Labs (CRLBF) United States $0.333B 0.00
VAREX IMAGING (VREX) United States $0.325B 11.94
Canopy Growth (CGC) Canada $0.314B 0.00
Aurora Cannabis (ACB) Canada $0.310B 55.20
Sanara MedTech (SMTI) United States $0.261B 0.00
Viemed Healthcare (VMD) United States $0.260B 21.90
ZimVie (ZIMV) United States $0.250B 11.35
Sanuwave Health (SNWV) United States $0.241B 0.00
Verano Holdings (VRNOF) United States $0.237B 0.00
Cerus (CERS) United States $0.235B 0.00
OraSure Technologies (OSUR) United States $0.212B 0.00
TriSalus Life Sciences (TLSI) United States $0.207B 0.00
Quanterix (QTRX) United States $0.203B 0.00
Brainsway (BWAY) Israel $0.197B 52.15
Biote (BTMD) United States $0.197B 5.53
Omeros (OMER) United States $0.195B 0.00
Organigram Global (OGI) Canada $0.185B 0.00
High Tide (HITI) Canada $0.177B 0.00
Utah Medical Products (UTMD) United States $0.177B 14.44
Exagen (XGN) United States $0.149B 0.00
FitLife Brands (FTLF) United States $0.142B 17.46
Jin Medical (ZJYL) China $0.119B 0.00
TerrAscend (TSNDF) Canada $0.110B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Fonar (FONR) United States $0.089B 11.52
MacroGenics (MGNX) United States $0.088B 0.00
Agape ATP (ATPC) $0.088B 0.00
Quipt Home Medical (QIPT) United States $0.077B 0.00
Veru (VERU) United States $0.075B 0.00
InterCure (INCR) Israel $0.072B 0.00
Zynex (ZYXI) United States $0.072B 0.00
Apyx Medical (APYX) United States $0.060B 0.00
Jushi Holdings (JUSHF) United States $0.058B 0.00
ImmuCell (ICCC) United States $0.057B 0.00
United Health Products (UEEC) United States $0.054B 0.00
Cytosorbents (CTSO) United States $0.051B 0.00
Modular Medical (MODD) United States $0.048B 0.00
United-Guardian (UG) United States $0.038B 13.19
Rockwell Medical (RMTI) United States $0.032B 0.00
Nephros (NEPH) United States $0.028B 37.57
Safety Shot (SHOT) United States $0.021B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
INLIF (INLF) $0.017B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
IM Cannabis (IMCC) Canada $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.011B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00